Patent ID: 8765178
Filing Date: 2014-07-01
Classification: A61K,A61P

Abstract:
1. A sustained release oral dosage pharmaceutical tablet, comprising: a. a first layer consisting of: b. at least two adjacent controlled release layers wherein at least one of said two adjacent controlled release layers consists of: said at least two adjacent layers being configured to regulate fluid access to a portion of the first layer, thereby controlling release of the first active agent from the first layer over the sustained period of time, wherein the configuration of the first layer and the two adjacent controlled release layers provides a T wherein fluid access is regulated in an amount sufficient to release the first active agent at a rate of from about 30% to about 45% after about 1 hour, from about 43% to about 75% after about 2 hours, and from about 80% to about 100% after about 4 hours.